These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10183358)

  • 1. "Tandem" high-dose chemoradiotherapy with autologous stem-cell support in the treatment of newly diagnosed or responsive multiple myeloma.
    Tecnologica MAP Suppl; 1998 Feb; ():32-4. PubMed ID: 10183358
    [No Abstract]   [Full Text] [Related]  

  • 2. Single or tandem high-dose chemoradiotherapy with autologous stem-cell support (HDC/AUSCS) for resistant multiple myeloma.
    Tecnologica MAP Suppl; 1999 Jan; ():17-9. PubMed ID: 10346745
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose chemotherapy with autologous stem-cell support for epithelial ovarian cancer.
    Tecnologica MAP Suppl; 1998 Feb; ():15-7. PubMed ID: 10183353
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose chemotherapy with autologous stem-cell support in the treatment of high-risk, primary breast cancer.
    Tecnologica MAP Suppl; 1999 Jan; ():8-10. PubMed ID: 10346740
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose chemotherapy with autologous stem-cell support for epithelial ovarian cancer.
    Tecnologica MAP Suppl; 1999 Jan; ():5-7. PubMed ID: 10346739
    [No Abstract]   [Full Text] [Related]  

  • 6. High dose lymphoablative therapy (HDLT) with or without stem cell rescue for treatment of severe autoimmune diseases.
    Tecnologica MAP Suppl; 2000 Apr; ():10-2. PubMed ID: 11010674
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose chemotherapy with autologous stem cell support in the treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Tecnologica MAP Suppl; 2000 Jan; ():17-9. PubMed ID: 10848119
    [No Abstract]   [Full Text] [Related]  

  • 8. Salvage high-dose chemotherapy with allogeneic stem-cell support for relapse following high dose chemotherapy with autologous stem-cell support for solid tumors.
    Tecnologica MAP Suppl; 1999 Jun; ():16-7. PubMed ID: 10848040
    [No Abstract]   [Full Text] [Related]  

  • 9. Salvage high-dose chemotherapy with allogeneic stem-cell support for relapse or incomplete remission following high-dose chemotherapy with autologous stem-cell transplantation for hematologic malignancies.
    Tecnologica MAP Suppl; 2000 Jun; ():16-9. PubMed ID: 11067684
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose lymphoablative therapy (HDLT) with or without autologous stem-cell rescue for treatment of severe autoimmune diseases.
    Tecnologica MAP Suppl; 2001 Dec; ():29-9. PubMed ID: 11933938
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose chemotherapy plus allogeneic stem cells to treat chronic lymphocytic leukemia or small lymphocytic lymphoma.
    TEC Bull (Online); 2002 Apr; 19(1):5-9. PubMed ID: 12166460
    [No Abstract]   [Full Text] [Related]  

  • 12. Colony-stimulating factor priming for collection of peripheral blood stem cells.
    Tecnologica; 1995 May; ():7-8. PubMed ID: 10168290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental and umbilical cord blood as a source of stem cells for hematopoietic support (Executive summary file).
    Tecnologica; 1996 Oct; ():7-10. PubMed ID: 10179815
    [No Abstract]   [Full Text] [Related]  

  • 14. Photodynamic therapy for subfoveal choroidal neovascularization.
    Tecnologica MAP Suppl; 2000 Sep; ():21-5. PubMed ID: 11503675
    [No Abstract]   [Full Text] [Related]  

  • 15. PET myocardial perfusion imaging for the detection of coronary artery disease--clinical assessment, vol. 10, no. 21, 1995.
    Tecnologica; 1996 Jan; ():7-8. PubMed ID: 10170484
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic vagus nerve stimulation for treatment of seizures.
    Tecnologica MAP Suppl; 1998 Feb; ():3-5. PubMed ID: 10183350
    [No Abstract]   [Full Text] [Related]  

  • 17. Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.
    Barlogie B; Kyle RA; Anderson KC; Greipp PR; Lazarus HM; Hurd DD; McCoy J; Moore DF; Dakhil SR; Lanier KS; Chapman RA; Cromer JN; Salmon SE; Durie B; Crowley JC
    J Clin Oncol; 2006 Feb; 24(6):929-36. PubMed ID: 16432076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External counterpulsation for treatment of chronic stable angina pectoris.
    Tecnologica MAP Suppl; 1999 Oct; ():3-5. PubMed ID: 10848082
    [No Abstract]   [Full Text] [Related]  

  • 19. External counterpulsation for treatment of chronic stable angina pectoris.
    Tecnologica MAP Suppl; 1998 May; ():3-5. PubMed ID: 10183367
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperbaric oxygen therapy for wound healing.
    Tecnologica MAP Suppl; 1999 Jun; ():7-12. PubMed ID: 10848038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.